PCN69 COST-EFFECTIVENESS ANALYSIS OF DASATINIB 100 MG VS. IMATINIB 800 MG IN PATIENTS WITH IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA IN SPAIN
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)71964-7
https://www.valueinhealthjournal.com/article/S1098-3015(11)71964-7/fulltext
Title :
PCN69 COST-EFFECTIVENESS ANALYSIS OF DASATINIB 100 MG VS. IMATINIB 800 MG IN PATIENTS WITH IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA IN SPAIN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71964-7&doi=10.1016/S1098-3015(11)71964-7
First page :
A264
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
126